Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps

References

• Settipane GA. Nasal polyps: epidemiology, pathology, immunology and treatment. Am J Rhinol 1987; 1: 119–26
   Google Scholar
• Iino, Y, Okura, S, Shiga, J, Toriyama, M, Kudo, K. Histopathological studies on paranasal mucsosa from patients treated with erythromycin. J Otolaryngol Jpn 1994;97:1070–8, (in Japanese with English abstract).
   Google Scholar
• Stammberger H. Examination and endoscopy of the nose and paranasal sinuses. Nasal polyposis; an inflammatory disease and its treatment, N Mygind, T Lildholdt. Munksgaard, Copenhagen 1997; 120–36
   Google Scholar
• Bachert C, Gavaert P, Holtappels G, Johansson SGO, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107: 607–14
   PubMed Web of Science ®Google Scholar
• Beck LA, Stellato C, Beall LD, Schall TJ, Leopold D, Bickel CA, et al. Allergens, IgE, mediators, inflammatory mechanisms: detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 1996; 98: 766–80
   PubMedGoogle Scholar
• Hamilos DL, Leung DY, Wood T, Bean DK, Schotman E, Hamid Q. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996; 15: 443–50
   PubMed Web of Science ®Google Scholar
• Shin S-H, Park J-Y, Jeon C-H, Choi J-K, Lee S-H. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope 2000; 110: 1353–7
   PubMedGoogle Scholar
• Hirashima M, Ueno M, Kamiya K-I, Higuchi S, Matsumoto R. Lymphokine Cytokine Res 1991; 10: 481–6
   PubMedGoogle Scholar
• Matsumoto R, Matsumoto H, Seki M, Hata M, Asano Y, Kanegasaki S, et al. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 1998; 273: 16976–84
   PubMed Web of Science ®Google Scholar
• Keith P, Dolovich J. Allergy and nasal polyposis. Nasal polyposis; an inflammatory disease and its treatment, N Mygind, T Lildholdt. Munksgaard, Copenhagen 1997; 120–36
   Google Scholar
• Ponath PD, Qin S, Ringler DJ, Clark-Lewis I, Wang J, Kassam N, et al. Cloning of the human eosinophil chemoattractant, eotaxin. Expression receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest 1996; 97: 604–12
   PubMed Web of Science ®Google Scholar
• Minshall EM, Cameron L, Lavigne F, Leung DY, Hamilos D, Garcia-Zepada EM, et al. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol 1997; 17: 683–90
   PubMed Web of Science ®Google Scholar
• Hamilos DL, Leung DYM, Huston DP, Kamil A, Sood R, Hamid Q. GM-CSF, IL-5, and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP). Clin Exp Allergy 1998; 28: 1145–52
   PubMed Web of Science ®Google Scholar
• Jahnsen FL, Haye R, Gran E, Brandtzaeg P, Johansen F-E. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. J Immunol 1999; 163: 1545–51
   PubMed Web of Science ®Google Scholar
• Lee CH, Lee KS, Rhee C-S, Lee SO, Min Y-G. Distribution of RANTES and interleukin-5 in allergic nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 1999; 108: 594–8
   PubMedGoogle Scholar
• Asakura H, Kashio Y, Nakamura K, Seki M, Dai S, Shirato Y, et al. Selective eosinophil adhesion to fibroblast via IFN-gamma-induced galectin-9. J Immunol 2002; 169: 5912–8
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Kumagai M, Sasaki N, Kurotaki H, Mori F, Seki M, Nishi N, et al. Interferon-gamma simulates the expression of galectin-9 in cultured human endothelial cells. J Leukoc Biol 2002; 72: 486–91
   PubMed Web of Science ®Google Scholar
• Matsumoto R, Hirashima M, Kita H, Gleich GJ. Biological activities of ecalectin: a novel eosinophil-activating factor. J Immunol 2002; 168: 1961–7
   PubMedGoogle Scholar
• Hirashima M, Hayashi H. The mediation of tissue eosinophilia in hypersensitivity reactions. I. Isolation of two different chemotactic factors from DNP-Ascaris extract-induced skin lesions in guinea pigs. Immunology 1976; 30: 203–12
   PubMedGoogle Scholar
• Rothenberg ME, Luster AD, Lilly CM, Drazen JM, Leder P. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J Exp Med 1995; 181: 1211–6
   PubMed Web of Science ®Google Scholar